Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (SHE:002223)
China flag China · Delayed Price · Currency is CNY
26.43
+0.44 (1.69%)
Aug 25, 2026, 3:04 PM CST

SHE:002223 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
1,1221,4821,8062,3961,5951,482
Depreciation & Amortization
270.25263.91252.22231.96222.38202.48
Other Amortization
64.5754.535.9730.7538.2441.27
Loss (Gain) From Sale of Assets
0.2-1.28-6.16-555.26-170.7-0.29
Asset Writedown & Restructuring Costs
9.229.0924.9554.6279.430.86
Loss (Gain) From Sale of Investments
-19.69-34.15-23.21-138.82-131.58-118
Provision & Write-off of Bad Debts
6.833.7620.87-9.4912.6627.08
Other Operating Activities
58.15-8.26-20.574.3-38.1352.77
Change in Accounts Receivable
458.7157.28-13.55169.4495.12308.95
Change in Inventory
-167.56-56.78-23.7462.71-259.43-302.81
Change in Accounts Payable
-268.8-358.67-101.09-375.6853.77-471.42
Change in Other Net Operating Assets
-14.76-6.613.92-5.0350.53-
Operating Cash Flow
1,5181,5031,8162,1272,3051,201
Operating Cash Flow Growth
-22.92%-17.25%-14.61%-7.72%91.88%-57.57%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-118.09-128.98-128.43-132.57-379.37-284.32
Sale of Property, Plant & Equipment
273.6475.934.7831.55201.650.72
Cash Acquisitions
----17.08-81.54-318.37
Investment in Securities
76.29-251.6496.371,764-267.42-1,806
Other Investing Activities
-6,361-6,3471.7889.49108.79579.67
Investing Cash Flow
-6,129-6,652-25.51,735-417.89-1,829

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
---200555.331,492
Total Debt Issued
---200555.331,492
Long-Term Debt Repaid
--20.87-1,207-1,113-49.09-654.39
Total Debt Repaid
-33.39-20.87-1,207-1,113-49.09-654.39
Net Debt Issued (Repaid)
-33.39-20.87-1,207-913.36506.24837.79
Issuance of Common Stock
--7.6199.6-149
Repurchase of Common Stock
-125.21----14.97-349.98
Common Dividends Paid
-1,001-799.01-1,224-660.58-350.81-318.85
Other Financing Activities
-6.22-1.9425.069.16214.43456.74
Financing Cash Flow
-1,166-821.82-2,399-1,465354.89774.7

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-81.74-51.9816.5424.2136.09-27.82
Net Cash Flow
-5,858-6,023-591.852,4212,378119.36

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
1,4001,3741,6881,9941,926916.88
Free Cash Flow Growth
-23.18%-18.60%-15.37%3.58%110.01%-57.39%
Free Cash Flow Margin
17.80%17.27%22.31%25.02%27.11%13.30%
Free Cash Flow Per Share
1.401.371.692.011.940.92
Levered Free Cash Flow
993.49111.27882.671,4471,205725.46
Unlevered Free Cash Flow
997.24115.02895.631,4841,241744.52

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
433.97608.33622.82904.42497.29448.59
Change in Working Capital
6.79-266.43-273.5743.06697.58-487.39